Skip to main content

Latest SEC Filings — Page 152

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Coincheck Q1 FY2027: Revenue Climbs 36% to ¥114.3B, Net Loss Narrows to ¥1.18B
Form 6-KCNCK · Form 6-K · 2026-08-14
Gabelli Group Cuts Sphere Stake Below 5%, Sells 141,500 Shares at $177
Form SCHEDULE 13D/ASPHR · Form SCHEDULE 13D/A · 2026-08-14
EDAP TMS Q2 2026: Revenue Up 39%, But EIB Warrant Charges Drive Net Loss to $14.5M
Form 10-QFOCL · Form 10-Q · 2026-08-14
Quoin Pharmaceuticals Reports Wider Loss, Reiterates Going Concern Doubt
ProForm 10-QQNRX · Form 10-Q · 2026-08-14
Streamex Q2 Loss Narrows to $14.6M, But Cash Drops to $5.6M and Material Weaknesses Persist
ProForm 10-QSTEX · Form 10-Q · 2026-08-14
LFC Q2 2026: Going Concern Persists, New Convertible Note Adds Dilution Risk
ProForm 10-QBOTY · Form 10-Q · 2026-08-14
VASO Corp Q2 2026: Net Income $544K, NetWolves Sale Finalized
Form 10-QVASO · Form 10-Q · 2026-08-14
Curis 10-Q Confirms $5.5M Offering, Going Concern Doubt Persists
ProForm 10-QCRIS · Form 10-Q · 2026-08-14
Oceanhawk 10-Q: Going Concern Doubt and Material Weakness Disclosed
ProForm 10-QOHAC · Form 10-Q · 2026-08-14
Sadot Group Reports Zero Revenue, Going Concern Doubt, and $42.4M Deconsolidation Gain
ProForm 10-QSDOT · Form 10-Q · 2026-08-14
Momentus Swaps Auditors, Dropping Frank Rimerman for Baker Tilly
ProForm 8-KMNTS · Form 8-K · 2026-08-14
First Post-Merger Quarter Yields $14.4M Net Loss for RTB Digital; $10M Digital Media Deposit Disclosed
ProForm 10-QRTB · Form 10-Q · 2026-08-14
Soluna Seeks Shareholder Approval for 167% Increase in Authorized Shares and $250M SEPA Financing
ProForm PRE 14ASLNH · Form PRE 14A · 2026-08-14
Direct Digital Holdings 10-Q: Going Concern, Covenant Breaches, and Nasdaq Deadline Today
ProForm 10-QDRCT · Form 10-Q · 2026-08-14
Functional Brands Reports $9.6M Loss, Defaults on Series C and Notes, Going Concern Doubt
ProForm 10-QMEHA · Form 10-Q · 2026-08-14
Precipio Q2 Revenue Jumps 24% but Going Concern Doubt Persists
ProForm 10-QPRPO · Form 10-Q · 2026-08-14
SPAC's Going Concern Warning Deepens as Cash Drops to $477
ProForm 10-QRTAC · Form 10-Q · 2026-08-14
SPAC Flags Going Concern Doubt as Business Combination Deadline Looms
ProForm 10-QEVAC · Form 10-Q · 2026-08-14
Quantum Leap 10-Q: Going Concern Reiterated, Disclosure Controls Ineffective
ProForm 10-QQLEP · Form 10-Q · 2026-08-14
Pony Group Q2 2026: Revenue Down 26%, Cash at $9.8K, Going Concern Doubt Reiterated
ProForm 10-QPNYG · Form 10-Q · 2026-08-14
Capital Bancorp Swaps Auditors, Taps Crowe for Scale and Specialization
ProForm 8-KCBNK · Form 8-K · 2026-08-14
GSR IV Posts Q2 Net Income of $1.76M, Flags Material Weakness in Internal Controls
ProForm 10-QGSRF · Form 10-Q · 2026-08-14
Smith Micro Q2 Loss Narrows but Going Concern Warning Persists
ProForm 10-QSMSI · Form 10-Q · 2026-08-14
CSPi Posts Q3 Loss, Declares Dividend, and Secures Seven-Figure Sports Contract
Form 8-KCSPI · Form 8-K · 2026-08-14
Merger Costs Drive Q2 Loss, Yet Assets Surge 47% at Ballston Spa Bancorp
Form 10-QBSPA · Form 10-Q · 2026-08-14
Cue Biopharma Q2 2026: $153.1M Net Loss, Cash at $17.4M, July Placement Adds $49.8M
ProForm 10-QCUE · Form 10-Q · 2026-08-14
Safe Pro Q2 Revenue Soars 1,336% but Material Weaknesses Persist
ProForm 10-QSPAI · Form 10-Q · 2026-08-14
Perfect Moment Posts Q1 Loss as Going Concern Worries Linger
ProForm 10-QPMNT · Form 10-Q · 2026-08-14
Vuzix Replaces ATM Sales Agreement with Jefferies, Upsizes to $100M
Form 424B5VUZI · Form 424B5 · 2026-08-14
Inhibitor Therapeutics Flags Going Concern, $3M Default Judgment, and FDA Path Forward
ProForm 10-QINTI · Form 10-Q · 2026-08-14